Controllable drug uptake and nongenomic response through estrogen-anchored cyclodextrin drug complex

Breast cancer is a leading killer of women worldwide. Cyclodextrin-based estrogen receptor-targeting drug-delivery systems represent a promising direction in cancer therapy but have rarely been investigated. To seek new targeting therapies for membrane estrogen receptor-positive breast cancer, an es...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Juan-Juan, Shumyak, Stepan P, Burgess, Christopher, Zhou, Zhi-Wei, He, Zhi-Xu, Zhang, Xue-Ji, Pan, Shu-Ting, Yang, Tian-Xin, Duan, Wei, Qiu, Jia-Xuan, Zhou, Shu-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524457/
https://www.ncbi.nlm.nih.gov/pubmed/26251594
http://dx.doi.org/10.2147/IJN.S82255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524457/
https://www.ncbi.nlm.nih.gov/pubmed/26251594
http://dx.doi.org/10.2147/IJN.S82255

Ejemplares similares